STOCK TITAN

Zymeworks (ZYME) EVP files Form 3 reporting no share ownership

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Zymeworks Inc. executive vice president and general counsel Paul R. Schneider filed an initial Form 3 indicating he currently has no securities beneficially owned in the company. The filing lists holding entries showing zero shares and no derivative securities, so it reflects a baseline ownership position of none.

Positive

  • None.

Negative

  • None.
Insider Schneider Paul R
Role EVP, General Counsel
Type Security Shares Price Value
holding No securities are beneficially owned -- -- --
holding No securities are beneficially owned -- -- --
Holdings After Transaction: No securities are beneficially owned — 0 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Total shares beneficially owned 0.0000 shares Total shares following holdings for Paul R. Schneider
Underlying derivative shares 0.0000 shares Underlying shares in derivative summary marked not applicable
Holding entries 2 entries Transaction summary shows two holding entries with unknown code
beneficially owned financial
"No securities are beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Form 3 regulatory
"initial Form 3 indicating he currently has no securities"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
reporting person regulatory
"The reporting person is Paul R. Schneider, who serves as"
derivative securities financial
"no derivative securities are beneficially owned by Paul R. Schneider"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Schneider Paul R

(Last)(First)(Middle)
C/O ZYMEWORKS INC.
108 PATRIOT DRIVE, SUITE A

(Street)
MIDDLETOWN DELAWARE 19709

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
05/13/2026
3. Issuer Name and Ticker or Trading Symbol
Zymeworks Inc. [ ZYME ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, General Counsel
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
No securities are beneficially owned0D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
No securities are beneficially owned (1) (1)Not applicable0(1)D
Explanation of Responses:
1. Not applicable.
Remarks:
Exhibit List - Exhibit 24 - Power of Attorney
/s/ Catherine Graham, Attorney-in-Fact05/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Paul R. Schneider’s Form 3 for ZYME show about his holdings?

The Form 3 shows Paul R. Schneider currently has no securities beneficially owned in Zymeworks Inc. It lists holding entries with zero shares and no applicable derivative securities, establishing a baseline of no reported ownership at this time.

Who is the reporting person on this Zymeworks Inc. (ZYME) Form 3?

The reporting person is Paul R. Schneider, who serves as executive vice president and general counsel at Zymeworks Inc. The filing classifies him as an officer and not a director or ten percent owner based on the disclosed roles.

Are there any buy or sell transactions reported in this ZYME Form 3?

No buy or sell transactions are reported in this Form 3 for Zymeworks Inc. The entries are categorized as holdings, with transaction summaries showing zero buy, sell, acquire, or dispose counts and only unknown holding entries with zero shares.

Does the Zymeworks Inc. Form 3 disclose any derivative securities for Paul R. Schneider?

The Form 3 indicates that no derivative securities are beneficially owned by Paul R. Schneider. The derivative summary lists “No securities are beneficially owned” with an underlying security marked “Not applicable” and underlying shares recorded as 0.0000.

What is the total number of ZYME shares Paul R. Schneider owns after this Form 3?

The Form 3 reports total shares following the reported holdings as 0.0000 for Paul R. Schneider. This means he has no reported direct beneficial ownership of Zymeworks Inc. common shares or related derivative securities as of the filing’s reported date.